Opaleye Management Inc.

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Value $
$571M
Signature - Title
James Silverman - President
Location
Boston, MA
Summary
This page shows a list of all the recent 13F filings made by Opaleye Management Inc.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Opaleye Management Inc. reported 39 stock holdings with total value $571M as of Q4 2024. Top holdings included HROW, TGTX, CDXS, ETON, and OCUL.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 39 $571M +$40.1M -$63.7M -$23.6M HROW, TGTX, CDXS, ETON, OCUL 13F-HR 2/14/2025, 04:05 PM
Q3 2024 44 $600M +$72.9M -$66.9M +$6.02M HROW, TGTX, OCUL, ARVN, CDXS 13F-HR 11/14/2024, 04:05 PM
Q2 2024 51 $438M +$72.2M -$59.2M +$13M HROW, TGTX, OCUL, RYTM, KROS 13F-HR 8/14/2024, 04:05 PM
Q1 2024 51 $455M +$76.9M -$77.5M -$609K OCUL, HROW, TGTX, KROS, RYTM Restatement 5/29/2024, 04:05 PM
Q4 2023 45 $372M +$63M -$56.4M +$6.61M HROW, TGTX, SLRN, RYTM, OCUL 13F-HR 2/14/2024, 04:05 PM
Q3 2023 53 $304M +$47.9M -$88.3M -$40.4M HROW, SLRN, OCUL, TGTX, RYTM 13F-HR 11/14/2023, 08:04 PM
Q2 2023 50 $415M +$135M -$34.6M +$100M SLRN, HROW, OCUL, TELA, CRNX 13F-HR 8/14/2023, 06:11 PM
Q1 2023 41 $334M +$42.1M -$6.65M +$35.5M HROW, OCUL, TELA, RYTM, CRNX 13F-HR 5/12/2023, 06:49 PM
Q4 2022 40 $288M +$59.8M -$21.8M +$38M HROW, TELA, RYTM, OCUL, CRNX 13F-HR 2/10/2023, 03:05 PM
Q3 2022 42 $242M +$30.5M -$14.3M +$16.2M HROW, OCUL, RYTM, TELA, CRNX 13F-HR 11/14/2022, 03:20 PM
Q2 2022 47 $222M +$35.6M -$30.8M +$4.78M HROW, OCUL, CDXS, CRNX, CYTK 13F-HR 8/15/2022, 04:03 PM
Q1 2022 44 $316M +$33.3M -$47.8M -$14.5M OCUL, CDXS, CMRX, HROW, CRNX 13F-HR 5/16/2022, 04:05 PM
Q4 2021 37 $466M +$50.2M -$30.8M +$19.4M CDXS, OCUL, CMRX, CLDX, HROW 13F-HR 2/14/2022, 03:05 PM
Q3 2021 48 $535M +$61M -$50M +$11M OCUL, CLDX, CDXS, CMRX, HROW 13F-HR 11/15/2021, 07:17 PM
Q2 2021 48 $602M +$45.2M -$90.3M -$45.1M OCUL, CMRX, CLDX, BBIO, CDXS 13F-HR 8/16/2021, 05:13 PM
Q1 2021 57 $671M +$147M -$168M -$21.4M OCUL, CMRX, TARA, BBIO, CDXS 13F-HR 5/17/2021, 07:03 PM
Q4 2020 57 $748M +$84.4M -$20M +$64.4M OCUL, TARA, EIDX, ETON, CDXS 13F-HR 2/12/2021, 04:15 PM
Q3 2020 49 $479M +$114M -$23.6M +$90.5M OCUL, TARA, ETON, CRDF, AFIB 13F-HR 11/16/2020, 03:30 PM
Q2 2020 47 $487M +$183M -$21.2M +$162M TARA, OCUL, NLTX, CCXI, ETON 13F-HR 8/14/2020, 04:47 PM
Q1 2020 44 $377M +$103M -$31.8M +$71.6M TARA, FTSV, OCUL, NLTX, CDXS 13F-HR 5/15/2020, 04:30 PM
Q4 2019 47 $510M +$106M -$2.84M +$104M EPZM, CDXS, FTSV, STXS, TPTX 13F-HR 2/14/2020, 03:30 PM
Q3 2019 49 $269M +$67.5M -$20.1M +$47.4M CDXS, STXS, EPZM, IMMY, EIDX 13F-HR 11/14/2019, 03:30 PM
Q2 2019 43 $318M +$63.5M -$15.9M +$47.6M CDXS, IMMY, AXGN, EPZM, QURE 13F-HR 8/14/2019, 04:30 PM
Q1 2019 53 $354M +$127M -$50.9M +$76.2M CDXS, AXGN, EPZM, CERC, AMRN 13F-HR 5/15/2019, 04:30 PM
Q4 2018 46 $268M +$47.4M -$19.3M +$28.2M CDXS, AXGN, LOXO, AMRN, BPMC 13F-HR 2/14/2019, 04:00 PM
Q3 2018 46 $393M +$45M -$41.6M +$3.35M AXGN, CDXS, LOXO, AMRN, BPMC 13F-HR 11/14/2018, 03:30 PM
Q2 2018 35 $383M +$94.3M -$33.1M +$61.2M AXGN, LOXO, CDXS, FGEN, BPMC 13F-HR 8/14/2018, 04:31 PM
Q1 2018 37 $329M +$54.6M -$23.7M +$30.8M AXGN, BPMC, LOXO, CDXS, FGEN 13F-HR 5/14/2018, 05:00 PM
Q4 2017 35 $302M +$53.2M -$5.22M +$48M AXGN, BPMC, FGEN, LOXO, IMMU 13F-HR 2/9/2018, 03:30 PM
Q3 2017 32 $281M +$36.5M -$12.3M +$24.2M BPMC, AXGN, FGEN, IMMU, LOXO 13F-HR 11/14/2017, 03:17 PM
Q2 2017 41 $238M +$36.2M -$2.69M +$33.5M BPMC, AXGN, FGEN, LOXO, SBBP 13F-HR 8/14/2017, 04:34 PM
Q1 2017 43 $198M +$40.9M -$8.45M +$32.4M BPMC, AXGN, FGEN, NVLNF, CMRX 13F-HR 5/15/2017, 06:15 AM
Q4 2016 39 $168M +$44.5M -$10.3M +$34.2M BPMC, AXGN, ARIA, GNMX, FGEN 13F-HR 2/21/2017, 03:27 PM
Q3 2016 43 $185M +$33M -$22.4M +$10.5M BPMC, AXGN, ARIA, MDGN, AGIO 13F-HR 11/14/2016, 11:30 AM
Q2 2016 49 $144M +$30.6M -$8.99M +$21.7M AXGN, MDGN, ARIA, FGEN, BPMC Restatement 8/12/2016, 04:35 PM
Q1 2016 50 $147M +$32.7M -$14M +$18.7M AXGN, ARIA, RARE, FGEN, MDGN Restatement 5/27/2016, 03:29 PM
Q4 2015 51 $231M +$45.5M -$18.1M +$27.4M RARE, AXGN, FGEN, GERN, MDGN 13F-HR 2/12/2016, 11:57 AM
Q3 2015 47 $199M +$31.8M -$24.1M +$7.78M CMRX, RARE, CEMP, AXGN, MDGN 13F-HR 11/13/2015, 09:44 AM
Q2 2015 43 $243M +$41.6M -$20.9M +$20.7M CMRX, CEMP, RTRX, AMAG, ARIA 13F-HR 8/14/2015, 10:27 AM
Q1 2015 37 $215M +$50.1M -$24.7M +$25.4M CMRX, CEMP, ARIA, RTRX, CLVSQ 13F-HR 5/15/2015, 11:41 AM
Q4 2014 36 $198M +$53.6M -$4.72M +$48.9M CMRX, AGIO, CEMP, RTRX, ARIA 13F-HR 2/13/2015, 06:06 AM
Q3 2014 28 $128M +$25.7M -$7.77M +$18M CMRX, PCYC, RTRX, ARIA, AGIO 13F-HR 11/14/2014, 09:27 AM
Q2 2014 27 $116M +$30.2M -$3.59M +$26.6M CMRX, RTRX, ARIA, PCYC, GNMK 13F-HR 8/14/2014, 10:19 AM
Q1 2014 30 $135M +$63.5M -$13.5M +$50M RTRX, ARIA, CMRX, PCYC, NSPR 13F-HR 5/15/2014, 10:48 AM
Q4 2013 21 $122M GENTY, GERN, PCYC, ARIA, P103PS 13F-HR 2/13/2014, 06:29 PM